Reducing Costs by Holding Back on Chemotherapy for Cancer Patients Who are Frail

This is the fourth in a series of posts on Bending the Cost Curve in Cancer Care, by Drs. Thomas J. Smith and Bruce E. Hillner, in a recent NEJM health policy piece. The authors’ third suggestion: to limit chemotherapy to patients with good performance status, with an exception for highly responsive disease, is surely one of the most […]

Posted in cancer treatment, Economics, health care costs, Medical Ethics, Oncology (cancer), PolicyTagged , , , , , , , , 5 Comments on Reducing Costs by Holding Back on Chemotherapy for Cancer Patients Who are Frail

News, and Thoughts, on Comparative Effectiveness Research

What is comparative effectiveness research and why does it matter? The idea, basically, is to inform medical decisions with relevant data derived from well-designed clinical trials. This sort of research will provide the foundation for evidence-based medicine (EBM).

Posted in Future of Medicine, health care costs, health care delivery, Medical Ethics, Policy, Public HealthTagged , , , Leave a Comment on News, and Thoughts, on Comparative Effectiveness Research

No More Clipboards

“This caught my interest because it doesn’t diminish physicians’ autonomy,” Blumenthal said. It just enables them to make decisions for their patients in the context of additional, current information. “The end goal is not to adopt technology, but to improve care.”

Posted in Communication, Future of Medicine, health care costs, health care delivery, Health IT, Policy, Public HealthTagged , , , , , , , Leave a Comment on No More Clipboards
newsletter software